ÂÜÀòÂÒÂ×

Amy Fisher concentrates her practice on the defense of complex, multidistrict litigation for pharmaceutical, medical device, and cosmetic manufacturers in federal and state courts. She oversees national litigations involving mass tort product liability claims and, over her more than two decades of experience, has led or co-chaired numerous national defense teams for nation-wide multidistrict litigation involving prescription and over-the-counter pharmaceuticals and medical devices.

Clients trust Amy to manage the overall strategy, day-to-day coordination, and complex discovery issues mass tort cases present. From initial case filings and consolidation, to bellwether management, trials, and beyond, Amy has a deep understanding of the substantive and procedural challenges facing clients in mass tort litigation. Drawing on her knowledge, Amy develops effective defense strategies designed to dispose of individual cases and entire dockets in a cost-efficient manner. Her experience includes management of a pharmaceutical multidistrict litigation in which nearly two thousand state and federal lawsuits were disposed of in less than two years through innovative and bifurcated case management and dispositive motions.

Amy regularly appears before the Judicial Panel on Multidistrict Litigation (JPML) to address the merits of centralization of various litigations and has significant experience with the JPML rules and procedures.